nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC1—Rifampicin—leprosy	0.338	0.435	CbGbCtD
Ofloxacin—ABCC2—Rifampicin—leprosy	0.25	0.322	CbGbCtD
Ofloxacin—CYP1A2—Thalidomide—leprosy	0.0962	0.124	CbGbCtD
Ofloxacin—CYP1A2—Rifampicin—leprosy	0.0932	0.12	CbGbCtD
Ofloxacin—Application site reaction—Dapsone—leprosy	0.00421	0.0192	CcSEcCtD
Ofloxacin—Swelling face—Dapsone—leprosy	0.00415	0.0189	CcSEcCtD
Ofloxacin—Nephrotic syndrome—Dapsone—leprosy	0.00408	0.0186	CcSEcCtD
Ofloxacin—TOP2A—Menadione—Thalidomide—leprosy	0.00379	1	CbGdCrCtD
Ofloxacin—Suicide attempt—Dapsone—leprosy	0.00348	0.0159	CcSEcCtD
Ofloxacin—Polyneuropathy—Thalidomide—leprosy	0.0031	0.0141	CcSEcCtD
Ofloxacin—Pyuria—Thalidomide—leprosy	0.00289	0.0132	CcSEcCtD
Ofloxacin—Albuminuria—Dapsone—leprosy	0.00264	0.0121	CcSEcCtD
Ofloxacin—Intestinal perforation—Thalidomide—leprosy	0.00256	0.0117	CcSEcCtD
Ofloxacin—Electrolyte imbalance—Thalidomide—leprosy	0.00242	0.011	CcSEcCtD
Ofloxacin—Erythema nodosum—Thalidomide—leprosy	0.00234	0.0106	CcSEcCtD
Ofloxacin—Dysaesthesia—Thalidomide—leprosy	0.00234	0.0106	CcSEcCtD
Ofloxacin—Proteinuria—Dapsone—leprosy	0.00225	0.0102	CcSEcCtD
Ofloxacin—Ascites—Thalidomide—leprosy	0.00222	0.0101	CcSEcCtD
Ofloxacin—Protein urine present—Dapsone—leprosy	0.00222	0.0101	CcSEcCtD
Ofloxacin—Lymphopenia—Thalidomide—leprosy	0.00197	0.009	CcSEcCtD
Ofloxacin—Skin exfoliation—Dapsone—leprosy	0.00188	0.00859	CcSEcCtD
Ofloxacin—Hostility—Thalidomide—leprosy	0.00182	0.00832	CcSEcCtD
Ofloxacin—Vesiculobullous rash—Thalidomide—leprosy	0.0018	0.00822	CcSEcCtD
Ofloxacin—Suicide attempt—Thalidomide—leprosy	0.00178	0.00812	CcSEcCtD
Ofloxacin—Enlargement abdomen—Thalidomide—leprosy	0.00168	0.00766	CcSEcCtD
Ofloxacin—Hypomagnesaemia—Thalidomide—leprosy	0.00159	0.00725	CcSEcCtD
Ofloxacin—Tooth disorder—Thalidomide—leprosy	0.00156	0.0071	CcSEcCtD
Ofloxacin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00148	0.00676	CcSEcCtD
Ofloxacin—Intestinal obstruction—Thalidomide—leprosy	0.00148	0.00676	CcSEcCtD
Ofloxacin—Interstitial lung disease—Thalidomide—leprosy	0.00143	0.00651	CcSEcCtD
Ofloxacin—Nystagmus—Thalidomide—leprosy	0.00141	0.00645	CcSEcCtD
Ofloxacin—Metrorrhagia—Thalidomide—leprosy	0.00141	0.00645	CcSEcCtD
Ofloxacin—Psychotic disorder—Dapsone—leprosy	0.0014	0.00638	CcSEcCtD
Ofloxacin—Stupor—Thalidomide—leprosy	0.00135	0.00617	CcSEcCtD
Ofloxacin—Albuminuria—Thalidomide—leprosy	0.00135	0.00617	CcSEcCtD
Ofloxacin—Pleural effusion—Thalidomide—leprosy	0.00132	0.00601	CcSEcCtD
Ofloxacin—Skin ulcer—Thalidomide—leprosy	0.0013	0.00592	CcSEcCtD
Ofloxacin—Hyperaesthesia—Thalidomide—leprosy	0.00129	0.00587	CcSEcCtD
Ofloxacin—Nasopharyngitis—Dapsone—leprosy	0.00128	0.00584	CcSEcCtD
Ofloxacin—Rash pustular—Thalidomide—leprosy	0.00127	0.00578	CcSEcCtD
Ofloxacin—Tingling sensation—Thalidomide—leprosy	0.00126	0.00573	CcSEcCtD
Ofloxacin—Petechiae—Thalidomide—leprosy	0.00123	0.0056	CcSEcCtD
Ofloxacin—Numbness—Thalidomide—leprosy	0.00122	0.00556	CcSEcCtD
Ofloxacin—Pancreatitis—Dapsone—leprosy	0.00121	0.00553	CcSEcCtD
Ofloxacin—Apnoea—Thalidomide—leprosy	0.00119	0.00543	CcSEcCtD
Ofloxacin—Sensory loss—Thalidomide—leprosy	0.00117	0.00532	CcSEcCtD
Ofloxacin—Proteinuria—Thalidomide—leprosy	0.00115	0.00524	CcSEcCtD
Ofloxacin—Vasodilation—Thalidomide—leprosy	0.00115	0.00524	CcSEcCtD
Ofloxacin—Vasodilation procedure—Thalidomide—leprosy	0.00115	0.00524	CcSEcCtD
Ofloxacin—Protein urine present—Thalidomide—leprosy	0.00113	0.00517	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Dapsone—leprosy	0.00113	0.00515	CcSEcCtD
Ofloxacin—Viral infection—Thalidomide—leprosy	0.00112	0.0051	CcSEcCtD
Ofloxacin—Arthropathy—Thalidomide—leprosy	0.00111	0.00506	CcSEcCtD
Ofloxacin—Oliguria—Thalidomide—leprosy	0.0011	0.005	CcSEcCtD
Ofloxacin—Herpes simplex—Thalidomide—leprosy	0.0011	0.005	CcSEcCtD
Ofloxacin—Drug interaction—Thalidomide—leprosy	0.00109	0.00497	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Dapsone—leprosy	0.00108	0.00493	CcSEcCtD
Ofloxacin—Leukocytosis—Thalidomide—leprosy	0.00108	0.0049	CcSEcCtD
Ofloxacin—Hearing impaired—Thalidomide—leprosy	0.00106	0.00484	CcSEcCtD
Ofloxacin—Creatinine increased—Thalidomide—leprosy	0.00106	0.00484	CcSEcCtD
Ofloxacin—Bone pain—Thalidomide—leprosy	0.00105	0.00481	CcSEcCtD
Ofloxacin—Atrioventricular block—Thalidomide—leprosy	0.00104	0.00475	CcSEcCtD
Ofloxacin—Sinusitis—Dapsone—leprosy	0.00104	0.00472	CcSEcCtD
Ofloxacin—Gait disturbance—Thalidomide—leprosy	0.00104	0.00472	CcSEcCtD
Ofloxacin—Coordination abnormal—Thalidomide—leprosy	0.00103	0.00469	CcSEcCtD
Ofloxacin—Phosphatase alkaline increased—Thalidomide—leprosy	0.00101	0.00461	CcSEcCtD
Ofloxacin—Pulmonary embolism—Thalidomide—leprosy	0.00101	0.00461	CcSEcCtD
Ofloxacin—Hyperkalaemia—Thalidomide—leprosy	0.000993	0.00453	CcSEcCtD
Ofloxacin—Pharyngitis—Dapsone—leprosy	0.000984	0.00448	CcSEcCtD
Ofloxacin—Depressed level of consciousness—Thalidomide—leprosy	0.000976	0.00445	CcSEcCtD
Ofloxacin—Colitis—Thalidomide—leprosy	0.00097	0.00442	CcSEcCtD
Ofloxacin—Candida infection—Thalidomide—leprosy	0.000965	0.0044	CcSEcCtD
Ofloxacin—Skin exfoliation—Thalidomide—leprosy	0.000965	0.0044	CcSEcCtD
Ofloxacin—Blood urea increased—Thalidomide—leprosy	0.000954	0.00435	CcSEcCtD
Ofloxacin—Aplastic anaemia—Thalidomide—leprosy	0.000949	0.00432	CcSEcCtD
Ofloxacin—Neuropathy—Thalidomide—leprosy	0.000949	0.00432	CcSEcCtD
Ofloxacin—Dry eye—Thalidomide—leprosy	0.000933	0.00425	CcSEcCtD
Ofloxacin—Cramps of lower extremities—Thalidomide—leprosy	0.000928	0.00423	CcSEcCtD
Ofloxacin—Tinnitus—Dapsone—leprosy	0.000924	0.00421	CcSEcCtD
Ofloxacin—Oesophagitis—Thalidomide—leprosy	0.000923	0.00421	CcSEcCtD
Ofloxacin—Rash maculo-papular—Thalidomide—leprosy	0.000918	0.00419	CcSEcCtD
Ofloxacin—Lightheadedness—Thalidomide—leprosy	0.000904	0.00412	CcSEcCtD
Ofloxacin—Pulmonary oedema—Thalidomide—leprosy	0.000899	0.0041	CcSEcCtD
Ofloxacin—Hypertonia—Thalidomide—leprosy	0.000886	0.00404	CcSEcCtD
Ofloxacin—Hyperkinesia—Thalidomide—leprosy	0.000881	0.00402	CcSEcCtD
Ofloxacin—Sepsis—Thalidomide—leprosy	0.000877	0.004	CcSEcCtD
Ofloxacin—Euphoric mood—Thalidomide—leprosy	0.000868	0.00396	CcSEcCtD
Ofloxacin—Erythema—Dapsone—leprosy	0.000863	0.00393	CcSEcCtD
Ofloxacin—Lymphadenopathy—Thalidomide—leprosy	0.00086	0.00392	CcSEcCtD
Ofloxacin—Thrombophlebitis—Thalidomide—leprosy	0.000847	0.00386	CcSEcCtD
Ofloxacin—Diabetes mellitus—Thalidomide—leprosy	0.000843	0.00384	CcSEcCtD
Ofloxacin—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000843	0.00384	CcSEcCtD
Ofloxacin—Photosensitivity—Thalidomide—leprosy	0.000835	0.00381	CcSEcCtD
Ofloxacin—Gastroenteritis—Thalidomide—leprosy	0.000827	0.00377	CcSEcCtD
Ofloxacin—Vascular purpura—Thalidomide—leprosy	0.00082	0.00374	CcSEcCtD
Ofloxacin—Deafness—Thalidomide—leprosy	0.00082	0.00374	CcSEcCtD
Ofloxacin—Eczema—Thalidomide—leprosy	0.000816	0.00372	CcSEcCtD
Ofloxacin—Vision blurred—Dapsone—leprosy	0.000813	0.00371	CcSEcCtD
Ofloxacin—Eye pain—Thalidomide—leprosy	0.000812	0.0037	CcSEcCtD
Ofloxacin—Renal failure acute—Thalidomide—leprosy	0.000794	0.00362	CcSEcCtD
Ofloxacin—Amnesia—Thalidomide—leprosy	0.000781	0.00356	CcSEcCtD
Ofloxacin—Dermatitis exfoliative—Thalidomide—leprosy	0.000777	0.00354	CcSEcCtD
Ofloxacin—Vertigo—Dapsone—leprosy	0.000775	0.00353	CcSEcCtD
Ofloxacin—Visual disturbance—Thalidomide—leprosy	0.000774	0.00353	CcSEcCtD
Ofloxacin—Atrial fibrillation—Thalidomide—leprosy	0.000774	0.00353	CcSEcCtD
Ofloxacin—Dermatitis bullous—Thalidomide—leprosy	0.000767	0.0035	CcSEcCtD
Ofloxacin—Purpura—Thalidomide—leprosy	0.000761	0.00347	CcSEcCtD
Ofloxacin—Arthritis—Thalidomide—leprosy	0.000755	0.00344	CcSEcCtD
Ofloxacin—Cough—Dapsone—leprosy	0.000753	0.00343	CcSEcCtD
Ofloxacin—Hypoglycaemia—Thalidomide—leprosy	0.000751	0.00343	CcSEcCtD
Ofloxacin—Cardiac failure—Thalidomide—leprosy	0.000751	0.00343	CcSEcCtD
Ofloxacin—Cerebrovascular accident—Thalidomide—leprosy	0.000748	0.00341	CcSEcCtD
Ofloxacin—Hyponatraemia—Thalidomide—leprosy	0.000736	0.00336	CcSEcCtD
Ofloxacin—Diplopia—Thalidomide—leprosy	0.000733	0.00334	CcSEcCtD
Ofloxacin—Osteoarthritis—Thalidomide—leprosy	0.000733	0.00334	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000733	0.00334	CcSEcCtD
Ofloxacin—Pain in extremity—Thalidomide—leprosy	0.000733	0.00334	CcSEcCtD
Ofloxacin—Affect lability—Thalidomide—leprosy	0.000722	0.00329	CcSEcCtD
Ofloxacin—Migraine—Thalidomide—leprosy	0.000722	0.00329	CcSEcCtD
Ofloxacin—Psychotic disorder—Thalidomide—leprosy	0.000716	0.00327	CcSEcCtD
Ofloxacin—Face oedema—Thalidomide—leprosy	0.000708	0.00323	CcSEcCtD
Ofloxacin—Cardiac arrest—Thalidomide—leprosy	0.000697	0.00318	CcSEcCtD
Ofloxacin—Mood swings—Thalidomide—leprosy	0.000695	0.00317	CcSEcCtD
Ofloxacin—Ataxia—Thalidomide—leprosy	0.00069	0.00314	CcSEcCtD
Ofloxacin—Tachycardia—Dapsone—leprosy	0.000687	0.00313	CcSEcCtD
Ofloxacin—Blood creatinine increased—Thalidomide—leprosy	0.000687	0.00313	CcSEcCtD
Ofloxacin—Dehydration—Thalidomide—leprosy	0.000682	0.00311	CcSEcCtD
Ofloxacin—Dry skin—Thalidomide—leprosy	0.000672	0.00306	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Thalidomide—leprosy	0.00067	0.00305	CcSEcCtD
Ofloxacin—Hypokalaemia—Thalidomide—leprosy	0.000667	0.00304	CcSEcCtD
Ofloxacin—Breast disorder—Thalidomide—leprosy	0.000663	0.00302	CcSEcCtD
Ofloxacin—Cramp muscle—Thalidomide—leprosy	0.00066	0.00301	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00066	0.00301	CcSEcCtD
Ofloxacin—Abdominal distension—Thalidomide—leprosy	0.000638	0.00291	CcSEcCtD
Ofloxacin—Insomnia—Dapsone—leprosy	0.000637	0.0029	CcSEcCtD
Ofloxacin—Dysphagia—Thalidomide—leprosy	0.000634	0.00289	CcSEcCtD
Ofloxacin—Eosinophilia—Thalidomide—leprosy	0.000628	0.00286	CcSEcCtD
Ofloxacin—Bronchospasm—Thalidomide—leprosy	0.000623	0.00284	CcSEcCtD
Ofloxacin—Pancreatitis—Thalidomide—leprosy	0.000621	0.00283	CcSEcCtD
Ofloxacin—Angina pectoris—Thalidomide—leprosy	0.000617	0.00281	CcSEcCtD
Ofloxacin—Bronchitis—Thalidomide—leprosy	0.00061	0.00278	CcSEcCtD
Ofloxacin—Pancytopenia—Thalidomide—leprosy	0.000602	0.00274	CcSEcCtD
Ofloxacin—Neutropenia—Thalidomide—leprosy	0.000593	0.0027	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Thalidomide—leprosy	0.000589	0.00269	CcSEcCtD
Ofloxacin—Pollakiuria—Thalidomide—leprosy	0.000586	0.00267	CcSEcCtD
Ofloxacin—Erectile dysfunction—Thalidomide—leprosy	0.000584	0.00266	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Thalidomide—leprosy	0.000579	0.00264	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Dapsone—leprosy	0.000576	0.00262	CcSEcCtD
Ofloxacin—Weight decreased—Thalidomide—leprosy	0.000573	0.00261	CcSEcCtD
Ofloxacin—Hyperglycaemia—Thalidomide—leprosy	0.000572	0.00261	CcSEcCtD
Ofloxacin—Pneumonia—Thalidomide—leprosy	0.000568	0.00259	CcSEcCtD
Ofloxacin—Infestation—Thalidomide—leprosy	0.000565	0.00258	CcSEcCtD
Ofloxacin—Drowsiness—Thalidomide—leprosy	0.000565	0.00258	CcSEcCtD
Ofloxacin—Infestation NOS—Thalidomide—leprosy	0.000565	0.00258	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00056	0.00255	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Thalidomide—leprosy	0.000557	0.00254	CcSEcCtD
Ofloxacin—Abdominal pain—Dapsone—leprosy	0.000557	0.00254	CcSEcCtD
Ofloxacin—Body temperature increased—Dapsone—leprosy	0.000557	0.00254	CcSEcCtD
Ofloxacin—Renal failure—Thalidomide—leprosy	0.000556	0.00253	CcSEcCtD
Ofloxacin—Myocardial infarction—Thalidomide—leprosy	0.000554	0.00253	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Thalidomide—leprosy	0.000554	0.00253	CcSEcCtD
Ofloxacin—Stomatitis—Thalidomide—leprosy	0.000551	0.00251	CcSEcCtD
Ofloxacin—Conjunctivitis—Thalidomide—leprosy	0.000549	0.0025	CcSEcCtD
Ofloxacin—Haematuria—Thalidomide—leprosy	0.000539	0.00246	CcSEcCtD
Ofloxacin—Epistaxis—Thalidomide—leprosy	0.000533	0.00243	CcSEcCtD
Ofloxacin—Sinusitis—Thalidomide—leprosy	0.00053	0.00242	CcSEcCtD
Ofloxacin—Agranulocytosis—Thalidomide—leprosy	0.000527	0.0024	CcSEcCtD
Ofloxacin—Bradycardia—Thalidomide—leprosy	0.000517	0.00235	CcSEcCtD
Ofloxacin—Rhinitis—Thalidomide—leprosy	0.000509	0.00232	CcSEcCtD
Ofloxacin—Hepatitis—Thalidomide—leprosy	0.000507	0.00231	CcSEcCtD
Ofloxacin—Hypoaesthesia—Thalidomide—leprosy	0.000505	0.0023	CcSEcCtD
Ofloxacin—Pharyngitis—Thalidomide—leprosy	0.000504	0.0023	CcSEcCtD
Ofloxacin—Urinary tract disorder—Thalidomide—leprosy	0.000501	0.00228	CcSEcCtD
Ofloxacin—Oedema peripheral—Thalidomide—leprosy	0.0005	0.00228	CcSEcCtD
Ofloxacin—Urethral disorder—Thalidomide—leprosy	0.000497	0.00227	CcSEcCtD
Ofloxacin—Visual impairment—Thalidomide—leprosy	0.000489	0.00223	CcSEcCtD
Ofloxacin—Erythema multiforme—Thalidomide—leprosy	0.00048	0.00219	CcSEcCtD
Ofloxacin—Eye disorder—Thalidomide—leprosy	0.000474	0.00216	CcSEcCtD
Ofloxacin—Tinnitus—Thalidomide—leprosy	0.000473	0.00216	CcSEcCtD
Ofloxacin—Cardiac disorder—Thalidomide—leprosy	0.000471	0.00215	CcSEcCtD
Ofloxacin—Angiopathy—Thalidomide—leprosy	0.00046	0.0021	CcSEcCtD
Ofloxacin—Immune system disorder—Thalidomide—leprosy	0.000458	0.00209	CcSEcCtD
Ofloxacin—Mediastinal disorder—Thalidomide—leprosy	0.000457	0.00208	CcSEcCtD
Ofloxacin—Chills—Thalidomide—leprosy	0.000455	0.00208	CcSEcCtD
Ofloxacin—Arrhythmia—Thalidomide—leprosy	0.000453	0.00207	CcSEcCtD
Ofloxacin—Alopecia—Thalidomide—leprosy	0.000448	0.00204	CcSEcCtD
Ofloxacin—Vomiting—Dapsone—leprosy	0.000448	0.00204	CcSEcCtD
Ofloxacin—Mental disorder—Thalidomide—leprosy	0.000444	0.00203	CcSEcCtD
Ofloxacin—Malnutrition—Thalidomide—leprosy	0.000442	0.00201	CcSEcCtD
Ofloxacin—Headache—Dapsone—leprosy	0.000441	0.00201	CcSEcCtD
Ofloxacin—Flatulence—Thalidomide—leprosy	0.000435	0.00198	CcSEcCtD
Ofloxacin—Tension—Thalidomide—leprosy	0.000433	0.00198	CcSEcCtD
Ofloxacin—Dysgeusia—Thalidomide—leprosy	0.000433	0.00197	CcSEcCtD
Ofloxacin—Nervousness—Thalidomide—leprosy	0.000429	0.00196	CcSEcCtD
Ofloxacin—Back pain—Thalidomide—leprosy	0.000427	0.00195	CcSEcCtD
Ofloxacin—Muscle spasms—Thalidomide—leprosy	0.000425	0.00194	CcSEcCtD
Ofloxacin—Nausea—Dapsone—leprosy	0.000418	0.00191	CcSEcCtD
Ofloxacin—Vision blurred—Thalidomide—leprosy	0.000416	0.0019	CcSEcCtD
Ofloxacin—Tremor—Thalidomide—leprosy	0.000414	0.00189	CcSEcCtD
Ofloxacin—Ill-defined disorder—Thalidomide—leprosy	0.00041	0.00187	CcSEcCtD
Ofloxacin—Anaemia—Thalidomide—leprosy	0.000408	0.00186	CcSEcCtD
Ofloxacin—Agitation—Thalidomide—leprosy	0.000406	0.00185	CcSEcCtD
Ofloxacin—Angioedema—Thalidomide—leprosy	0.000404	0.00184	CcSEcCtD
Ofloxacin—Malaise—Thalidomide—leprosy	0.000398	0.00182	CcSEcCtD
Ofloxacin—Vertigo—Thalidomide—leprosy	0.000397	0.00181	CcSEcCtD
Ofloxacin—Syncope—Thalidomide—leprosy	0.000396	0.00181	CcSEcCtD
Ofloxacin—Leukopenia—Thalidomide—leprosy	0.000395	0.0018	CcSEcCtD
Ofloxacin—Palpitations—Thalidomide—leprosy	0.00039	0.00178	CcSEcCtD
Ofloxacin—Loss of consciousness—Thalidomide—leprosy	0.000388	0.00177	CcSEcCtD
Ofloxacin—Cough—Thalidomide—leprosy	0.000385	0.00176	CcSEcCtD
Ofloxacin—Hypertension—Thalidomide—leprosy	0.000381	0.00174	CcSEcCtD
Ofloxacin—Chest pain—Thalidomide—leprosy	0.000376	0.00171	CcSEcCtD
Ofloxacin—Myalgia—Thalidomide—leprosy	0.000376	0.00171	CcSEcCtD
Ofloxacin—Arthralgia—Thalidomide—leprosy	0.000376	0.00171	CcSEcCtD
Ofloxacin—Anxiety—Thalidomide—leprosy	0.000375	0.00171	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000373	0.0017	CcSEcCtD
Ofloxacin—Discomfort—Thalidomide—leprosy	0.000372	0.00169	CcSEcCtD
Ofloxacin—Dry mouth—Thalidomide—leprosy	0.000368	0.00168	CcSEcCtD
Ofloxacin—Confusional state—Thalidomide—leprosy	0.000363	0.00166	CcSEcCtD
Ofloxacin—Oedema—Thalidomide—leprosy	0.00036	0.00164	CcSEcCtD
Ofloxacin—Infection—Thalidomide—leprosy	0.000358	0.00163	CcSEcCtD
Ofloxacin—Shock—Thalidomide—leprosy	0.000355	0.00162	CcSEcCtD
Ofloxacin—Nervous system disorder—Thalidomide—leprosy	0.000353	0.00161	CcSEcCtD
Ofloxacin—Thrombocytopenia—Thalidomide—leprosy	0.000353	0.00161	CcSEcCtD
Ofloxacin—Tachycardia—Thalidomide—leprosy	0.000352	0.0016	CcSEcCtD
Ofloxacin—Skin disorder—Thalidomide—leprosy	0.00035	0.0016	CcSEcCtD
Ofloxacin—Hyperhidrosis—Thalidomide—leprosy	0.000348	0.00159	CcSEcCtD
Ofloxacin—Anorexia—Thalidomide—leprosy	0.000344	0.00157	CcSEcCtD
Ofloxacin—Hypotension—Thalidomide—leprosy	0.000337	0.00154	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000328	0.0015	CcSEcCtD
Ofloxacin—Insomnia—Thalidomide—leprosy	0.000326	0.00149	CcSEcCtD
Ofloxacin—Paraesthesia—Thalidomide—leprosy	0.000324	0.00148	CcSEcCtD
Ofloxacin—Dyspnoea—Thalidomide—leprosy	0.000321	0.00147	CcSEcCtD
Ofloxacin—Somnolence—Thalidomide—leprosy	0.00032	0.00146	CcSEcCtD
Ofloxacin—Dyspepsia—Thalidomide—leprosy	0.000317	0.00145	CcSEcCtD
Ofloxacin—Decreased appetite—Thalidomide—leprosy	0.000313	0.00143	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Thalidomide—leprosy	0.000311	0.00142	CcSEcCtD
Ofloxacin—Fatigue—Thalidomide—leprosy	0.000311	0.00142	CcSEcCtD
Ofloxacin—Constipation—Thalidomide—leprosy	0.000308	0.00141	CcSEcCtD
Ofloxacin—Pain—Thalidomide—leprosy	0.000308	0.00141	CcSEcCtD
Ofloxacin—Feeling abnormal—Thalidomide—leprosy	0.000297	0.00135	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Thalidomide—leprosy	0.000295	0.00134	CcSEcCtD
Ofloxacin—Urticaria—Thalidomide—leprosy	0.000286	0.00131	CcSEcCtD
Ofloxacin—Abdominal pain—Thalidomide—leprosy	0.000285	0.0013	CcSEcCtD
Ofloxacin—Body temperature increased—Thalidomide—leprosy	0.000285	0.0013	CcSEcCtD
Ofloxacin—Hypersensitivity—Thalidomide—leprosy	0.000266	0.00121	CcSEcCtD
Ofloxacin—Asthenia—Thalidomide—leprosy	0.000259	0.00118	CcSEcCtD
Ofloxacin—Pruritus—Thalidomide—leprosy	0.000255	0.00116	CcSEcCtD
Ofloxacin—Diarrhoea—Thalidomide—leprosy	0.000247	0.00112	CcSEcCtD
Ofloxacin—Dizziness—Thalidomide—leprosy	0.000238	0.00109	CcSEcCtD
Ofloxacin—Vomiting—Thalidomide—leprosy	0.000229	0.00104	CcSEcCtD
Ofloxacin—Rash—Thalidomide—leprosy	0.000227	0.00104	CcSEcCtD
Ofloxacin—Dermatitis—Thalidomide—leprosy	0.000227	0.00104	CcSEcCtD
Ofloxacin—Headache—Thalidomide—leprosy	0.000226	0.00103	CcSEcCtD
Ofloxacin—Nausea—Thalidomide—leprosy	0.000214	0.000976	CcSEcCtD
